Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzalutamide Alone or With Radium223 in Men With Metastatic, Castration-Resistant Prostate Cancer
NCT03344211Phase 2Active, not recruiting
- Sponsor
- University of Southern California
- Start
- Nov 2018
- Primary completion
- Dec 2026
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
A Phase 2 trial of radium-223 dichloride in prostate cancer (PCa), sponsored by University of Southern California. Started Nov 2018; status: active, not recruiting.
02
Drugs
radium-223 dichloride
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03344211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03344211.